LifeVantage Statistics
Total Valuation
LifeVantage has a market cap or net worth of $159.02 million. The enterprise value is $150.20 million.
| Market Cap | 159.02M |
| Enterprise Value | 150.20M |
Important Dates
The next estimated earnings date is Monday, May 5, 2025, after market close.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | Mar 3, 2025 |
Share Statistics
LifeVantage has 12.55 million shares outstanding. The number of shares has increased by 4.34% in one year.
| Current Share Class | 12.55M |
| Shares Outstanding | 12.55M |
| Shares Change (YoY) | +4.34% |
| Shares Change (QoQ) | +2.75% |
| Owned by Insiders (%) | 19.20% |
| Owned by Institutions (%) | 27.37% |
| Float | 8.61M |
Valuation Ratios
The trailing PE ratio is 22.51 and the forward PE ratio is 12.26.
| PE Ratio | 22.51 |
| Forward PE | 12.26 |
| PS Ratio | 0.73 |
| Forward PS | 0.61 |
| PB Ratio | 5.32 |
| P/TBV Ratio | 5.37 |
| P/FCF Ratio | 12.35 |
| P/OCF Ratio | 11.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.62, with an EV/FCF ratio of 11.66.
| EV / Earnings | 20.46 |
| EV / Sales | 0.71 |
| EV / EBITDA | 10.62 |
| EV / EBIT | 13.85 |
| EV / FCF | 11.66 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.43.
| Current Ratio | 1.66 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 0.79 |
| Debt / FCF | 0.99 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 25.67% and return on invested capital (ROIC) is 16.18%.
| Return on Equity (ROE) | 25.67% |
| Return on Assets (ROA) | 10.33% |
| Return on Invested Capital (ROIC) | 16.18% |
| Return on Capital Employed (ROCE) | 26.46% |
| Revenue Per Employee | $955,640 |
| Profits Per Employee | $33,063 |
| Employee Count | 222 |
| Asset Turnover | 3.23 |
| Inventory Turnover | 2.64 |
Taxes
In the past 12 months, LifeVantage has paid $2.96 million in taxes.
| Income Tax | 2.96M |
| Effective Tax Rate | 28.74% |
Stock Price Statistics
The stock price has increased by +99.53% in the last 52 weeks. The beta is 0.78, so LifeVantage's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +99.53% |
| 50-Day Moving Average | 15.66 |
| 200-Day Moving Average | 13.84 |
| Relative Strength Index (RSI) | 36.02 |
| Average Volume (20 Days) | 164,215 |
Short Selling Information
The latest short interest is 1.52 million, so 12.10% of the outstanding shares have been sold short.
| Short Interest | 1.52M |
| Short Previous Month | 1.60M |
| Short % of Shares Out | 12.10% |
| Short % of Float | 17.64% |
| Short Ratio (days to cover) | 8.60 |
Income Statement
In the last 12 months, LifeVantage had revenue of $212.15 million and earned $7.34 million in profits. Earnings per share was $0.56.
| Revenue | 212.15M |
| Gross Profit | 169.27M |
| Operating Income | 10.84M |
| Pretax Income | 4.19M |
| Net Income | 7.34M |
| EBITDA | 14.15M |
| EBIT | 10.84M |
| Earnings Per Share (EPS) | $0.56 |
Balance Sheet
The company has $21.60 million in cash and $12.77 million in debt, giving a net cash position of $8.83 million or $0.70 per share.
| Cash & Cash Equivalents | 21.60M |
| Total Debt | 12.77M |
| Net Cash | 8.83M |
| Net Cash Per Share | $0.70 |
| Equity (Book Value) | 29.89M |
| Book Value Per Share | 2.38 |
| Working Capital | 18.24M |
Cash Flow
In the last 12 months, operating cash flow was $14.29 million and capital expenditures -$1.41 million, giving a free cash flow of $12.88 million.
| Operating Cash Flow | 14.29M |
| Capital Expenditures | -1.41M |
| Free Cash Flow | 12.88M |
| FCF Per Share | $1.03 |
Margins
Gross margin is 79.79%, with operating and profit margins of 5.11% and 3.46%.
| Gross Margin | 79.79% |
| Operating Margin | 5.11% |
| Pretax Margin | 4.86% |
| Profit Margin | 3.46% |
| EBITDA Margin | 6.67% |
| EBIT Margin | 5.11% |
| FCF Margin | 6.07% |
Dividends & Yields
This stock pays an annual dividend of $0.16, which amounts to a dividend yield of 1.25%.
| Dividend Per Share | $0.16 |
| Dividend Yield | 1.25% |
| Dividend Growth (YoY) | -70.37% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 28.43% |
| Buyback Yield | -4.34% |
| Shareholder Yield | -3.08% |
| Earnings Yield | 4.62% |
| FCF Yield | 8.10% |
Analyst Forecast
The average price target for LifeVantage is $30.50, which is 138.65% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.50 |
| Price Target Difference | 138.65% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 19, 2015. It was a reverse split with a ratio of 0.1428571:1.
| Last Split Date | Oct 19, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.1428571:1 |
Scores
LifeVantage has an Altman Z-Score of 3.51 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.51 |
| Piotroski F-Score | 6 |